The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KIT resistance mutations identified by circulating tumor DNA and treatment outcomes in advanced gastrointestinal stromal tumor.
 
Steven Bialick
No Relationships to Disclose
 
Brandon Edward Rose
No Relationships to Disclose
 
Andrea P. Espejo-Freire
No Relationships to Disclose
 
Priscila Barreto Coelho
No Relationships to Disclose
 
Philippos Apolinario Costa
No Relationships to Disclose
 
Leticia Campoverde
No Relationships to Disclose
 
Leylah Drusbosky
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Travel, Accommodations, Expenses - Guardant Health
 
Junaid Arshad
No Relationships to Disclose
 
Cesar Serrano
Honoraria - Deciphera; PharmaMar
Consulting or Advisory Role - Blueprint Medicines; Captor Therapeutics Inc; Cogent Biosciences; Deciphera; Immunicum
Research Funding - Karyopharm Therapeutics (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Pfizer; PharmaMar
 
Suzanne George
Stock and Other Ownership Interests - Abbott Laboratories
Honoraria - CStone Pharmaceuticals
Consulting or Advisory Role - Bayer; Blueprint Medicines; Daiichi; deciphera; Immunicum; Kayothera; Lilly; MORE Health; Research to Practice; UpToDate
Research Funding - Blueprint Medicines (Inst); Daiichi Sankyo RD Novare (Inst); Deciphera (Inst); Eisai (Inst); Merck (Inst); SpringWorks Therapeutics (Inst); Theseus Pharmaceuticals (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Expert Testimony - Bayer
Other Relationship - Research to Practice; WCG
 
Sebastian Bauer
Honoraria - Bayer; Deciphera; GlaxoSmithKline; Novartis; Pfizer; Pharmamar
Consulting or Advisory Role - ADC Therapeutics; Adcendo; Bayer; Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo; Deciphera; Exelixis; GlaxoSmithKline; Janssen-Cilag; Lilly; Mundipharma; Nanobiotix
Research Funding - Blueprint Medicines; Incyte (Inst); Novartis
Travel, Accommodations, Expenses - Pharmamar
 
Neha Goel
No Relationships to Disclose
 
Shree Venkat
No Relationships to Disclose
 
Aditi Dhir
No Relationships to Disclose
 
Emily Jonczak
No Relationships to Disclose
 
Gina Z. D'Amato
Consulting or Advisory Role - Blueprint Medicines; Daiichi Sankyo/Lilly; Deciphera; Epizyme
 
Jonathan C. Trent
Consulting or Advisory Role - Agios; Bayer; Blueprint Medicines; C4 Therapeutics; Daiichi Sankyo; Deciphera; Epizyme; Janssen; Lilly; Novartis